N@N

Paradigm Medical Industries Inc.: Paradigm Medical Industries Signs Worldwide Distribution Agreement With CSO

^{Published on 2009-04-16 07:07:43, Last Modified on 2009-04-16 07:08:24 - Market Wire}
 

SALT LAKE CITY, UT--(Marketwire - April 16, 2009) - Paradigm Medical Industries, Inc. (OTCBB: [ PDMI ]) announced today that the Company signed a distribution agreement with Italian company, Costruzione Strumenti Oftalmici (CSO), whereas Paradigm will represent exclusively one of CSO's products in the US market, Retimax, the next generation for Standard Ocular Electrophysiology. The Retimax performs innovative tests for the early screening and follow-up of important pathologies like Glaucoma, ARM (age related Maculopaty), vascular retinal degeneration and other optic nerve diseases. Paradigm will also distribute additional ophthalmic products in the International and domestic markets.

CSO is an international leader for manufacturers of ophthalmic instruments with high technology solutions, great reliability and safety for users. The aptitude to the technology research, the reliability and the efficiency of the productive process, the highly trained staff, the high quality level of products and the maximum care for customer safety summarizes the production philosophy of CSO and the root of its long success becoming a leader in the international ophthalmic instruments market. CSO Quality System is certified in accordance with the ISO 9001 and ISO 13485 standard.

"This new partnership will create many new opportunities for both organizations," said Paradigm Medicals President, Stephen Davis. "We are excited to be chosen as CSO's exclusive distributor of their Retimax product in the domestic markets, we expect to do very well in the US. This new partnership will also open up new doors for future cooperative product development."

About Paradigm Medical Industries, Inc.

Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes cutting edge, new innovative products in the diagnostic ultrasound and early glaucoma detection markets. Paradigm has the only patented technology utilizing photon laser for cataract removal. The Company is poised to capture a niche market within the Glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States, as well as internationally.

For more information, please visit: [ www.paradigm-medical.com ]

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.